Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients

OBJECTIVES: To evaluate the 1-year cost-effectiveness between three different initial treatment strategies in autoantibody-negative RA patients, according to 2010 criteria. METHODS: For this analysis we selected all RA patients within the intermediate probability stratum of the treatment in the Rott...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathalie, Luurssen-Masurel, Mulligen, Van Elise, Maria, Weel Angelique Elisabeth Adriana, Wilhelmina, Hazes Johanna Maria, Pieter, de Jong Pascal Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645278/
https://www.ncbi.nlm.nih.gov/pubmed/33725091
http://dx.doi.org/10.1093/rheumatology/keab251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645278/
https://www.ncbi.nlm.nih.gov/pubmed/33725091
http://dx.doi.org/10.1093/rheumatology/keab251

Ejemplares similares